[go: up one dir, main page]

AR100404A1 - Polimorfos cristalinos de un derivado de piridina y método para producirlos - Google Patents

Polimorfos cristalinos de un derivado de piridina y método para producirlos

Info

Publication number
AR100404A1
AR100404A1 ARP150101454A ARP150101454A AR100404A1 AR 100404 A1 AR100404 A1 AR 100404A1 AR P150101454 A ARP150101454 A AR P150101454A AR P150101454 A ARP150101454 A AR P150101454A AR 100404 A1 AR100404 A1 AR 100404A1
Authority
AR
Argentina
Prior art keywords
polymorphes
producers
crystalline
pyridine derivative
crystal
Prior art date
Application number
ARP150101454A
Other languages
English (en)
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of AR100404A1 publication Critical patent/AR100404A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)

Abstract

Reivindicación 1: Un cristal del ácido 2-(5-cloropiridin-3-il)-1-(2,5-diclorobencil)-4-metil-1H-imidazol-5-carboxílico. Reivindicación 2: El cristal de acuerdo con la reivindicación 1, donde el cristal tiene una forma de cristal A. Reivindicación 10: El cristal de acuerdo con la reivindicación 1, donde el cristal tiene una forma de cristal B.
ARP150101454A 2014-05-13 2015-05-12 Polimorfos cristalinos de un derivado de piridina y método para producirlos AR100404A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014099678 2014-05-13

Publications (1)

Publication Number Publication Date
AR100404A1 true AR100404A1 (es) 2016-10-05

Family

ID=54479948

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150101454A AR100404A1 (es) 2014-05-13 2015-05-12 Polimorfos cristalinos de un derivado de piridina y método para producirlos

Country Status (15)

Country Link
US (1) US20170144987A1 (es)
EP (1) EP3144304A4 (es)
JP (1) JP6289619B2 (es)
KR (1) KR20170003569A (es)
CN (1) CN106458970B (es)
AR (1) AR100404A1 (es)
AU (1) AU2015260294A1 (es)
CA (1) CA2948792A1 (es)
IL (1) IL248901A0 (es)
MX (1) MX2016014692A (es)
PH (1) PH12016502222A1 (es)
RU (1) RU2016148736A (es)
SG (1) SG11201609483YA (es)
TW (1) TW201625580A (es)
WO (1) WO2015174411A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0513379T3 (da) * 1990-11-30 1996-09-30 Teijin Ltd 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne
US8148542B2 (en) * 2006-06-23 2012-04-03 Teijin Pharma Limited Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid
MX2010010366A (es) * 2008-03-31 2010-11-30 C & C Res Lab Derivados heterociclicos.
CN102333765B (zh) * 2009-02-27 2015-01-14 帝人制药株式会社 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法
WO2011007895A1 (ja) * 2009-07-15 2011-01-20 帝人ファーマ株式会社 貧溶媒添加法による２－（３－シアノ－４－イソブチルオキシフェニル）－４－メチル－５－チアゾールカルボン酸の結晶多形体の製造方法
JP5519201B2 (ja) * 2009-07-15 2014-06-11 光孝 北村 ２−（３−シアノ−４−イソブチルオキシフェニル）−４−メチル−５−チアゾールカルボン酸の結晶多形体の製造方法
KR101800054B1 (ko) * 2010-08-27 2017-11-21 데이진 화-마 가부시키가이샤 팔라듐 화합물을 사용한 커플링법에 의한 페닐 치환 복소 고리 유도체의 제조법
US9637469B2 (en) * 2012-11-14 2017-05-02 Teijin Pharma Limited Pyridine derivative

Also Published As

Publication number Publication date
SG11201609483YA (en) 2016-12-29
CN106458970B (zh) 2019-09-13
RU2016148736A3 (es) 2018-06-14
US20170144987A1 (en) 2017-05-25
CN106458970A (zh) 2017-02-22
MX2016014692A (es) 2017-02-23
EP3144304A1 (en) 2017-03-22
IL248901A0 (en) 2017-01-31
RU2016148736A (ru) 2018-06-14
AU2015260294A1 (en) 2017-01-05
JPWO2015174411A1 (ja) 2017-04-20
TW201625580A (zh) 2016-07-16
KR20170003569A (ko) 2017-01-09
EP3144304A4 (en) 2017-10-25
WO2015174411A1 (ja) 2015-11-19
PH12016502222A1 (en) 2017-02-06
JP6289619B2 (ja) 2018-03-07
CA2948792A1 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
HUE062136T2 (hu) Eljárás hõre lágyuló kopásálló fólia elõállítására
HUE057926T2 (hu) Eljárás tiokarbonátok elõállítására
HUE067017T2 (hu) Eljárás poliolok gyártására
BR112017003051A2 (pt) composto, método para produção de material magnético
MX2019011758A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
DK3142785T3 (da) Fremgangsmåde til fremstilling af alkenoler og anvendelse deraf til fremstilling af 1,3-butadien
ME03004B (me) Postupak za proizvodnju stabilnog, injektabilnog rastvora noradrenalina niske koncentracije
MX2020008507A (es) Metodo para producir 1,1,3,3-tetracloropropeno.
CL2016001095A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
LT3200817T (lt) Būdas ir kompozicija, skirti sustiprintų priešuždegiminių/antikatabolinių ir regeneracinių agentų gamybai iš autologinio kraujo
MX2019011730A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
AR101368A1 (es) Forma cristalina de sofosbuvir y proceso para su preparación
HUE053000T2 (hu) Eljárás stabilizátorok elõállítására
ITUA20163404A1 (it) Linea per la produzione di bobine di materiale nastriforme
IN2014MU00455A (es)
HUE044577T2 (hu) Eljárás karbamid elõállítására
EP3184557C0 (en) PROCESS FOR PREPARING POLYBUTENE
HUE059378T2 (hu) Szigetelõfólia, valamint szigetelõfólia elõállítására szolgáló eljárás
HUE057514T2 (hu) Eljárás aszimmetrikus láncú karbonát elõállítására
HUE060213T2 (hu) Javított eljárások T-sejtek elõállítására
BR112017000697A2 (pt) “processo para a produção de compostos de biaril”
ITBA20140018A1 (it) Macchinario per la produzione di stracciatella
BR112016019079A2 (pt) método para a produção de dimetacrilato de glicerol de alta pureza.
HUE064895T2 (hu) Eljárás palbociklib elõállítására
AR100404A1 (es) Polimorfos cristalinos de un derivado de piridina y método para producirlos

Legal Events

Date Code Title Description
FB Suspension of granting procedure